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Amongst the sport dietary supplements, those manufactured with whey protein (WP) represent an
important amino acid source. However, as a result of product lack of uniformity, the nutritional quality of
this type of product is uncertain. Thus, the aim of this study was to investigate the protein quality of WP
supplements produced by U.S. (WP-USA), and Brazilian companies (WP-BRA), evaluating the in vitro
protein digestibility, and the essential amino acid (EEA) composition. In addition, the amino acid (AAS)
and protein digestibility-corrected amino acid (PDCAAS) scores were calculated. Although WP-USA
supplement exhibited greater (P < 0.05) digestibility than WP-BRA counterparts, both WP supple-
ments exhibited greater (P < 0.05) digestibility than soy and caseinate isolate supplements, which were
used as reference. Considering the WHO/FAO/UNU protein standard for non-athletic adult, the WP-USA
and WP-BRA supplements scored high AAS. In addition, the PDCAAS values on both supplement groups
were >1.0, with exception of threonine and valine in WP-USA, and isoleucine and leucine in WP-BRA.
However, when the calculated AAS and PDCAAS based on the suggestion for adult athletes were
considered, both supplements exhibited suboptimal score values for several EAA. In addition, both WP-
USA and WP-BRA supplements were unable to supply the suggested adult athlete EAA requirement.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Protein supplements are one of the most widely consumed
supplements by athletes and physically active individuals (Phillips,
2012). Amongst the ingredients used to manufacture this type of
product (i.e. caseinates, whey, egg, soy, and wheat proteins), whey
protein (WP) is the most commercialized in the sports nutrition
market due to its high nutritional value when compared to other
proteins sources (Ha & Zemel, 2003; Khanam, Kumkum, &
Swamylingappa, 2013). WP represents 20e30% of the proteins
present in bovine milk; it is a complex mixture of globular protein
molecules consisting mostly of a-lactalbumin (a-La), b-lactoglob-
ulin (b-Lg) (Urista, Fernandez, Rodriguez, Cuenca, & Tellez, 2011).
The protein fractions a-La and b-Lg (variants A and B) represent
almost 70% of the proteins present in whey (Walstra, Wouters, &
Geurts, 2006).unior).Differences in the physicalechemical composition of WP sup-
plements potentially inﬂuence its nutritional effect on the human
body (Manninen, 2009). The nutritional quality of WP supplement
depends on amino acid composition, bioavailability of essential
amino acids, protein digestibility, and physiological utilization of
speciﬁc amino acids after digestion and absorption (Lemon, Berardi,
& Noreen, 2002). Whey protein is considered an important source
of essential amino acids (EAA), of which the branched-chain amino
acids (BCAA) leucine, isoleucine and valine have been associated
with increased stimulus of skeletal muscle protein synthesis
(Rankin & Darragh, 2006).
Moreover, protein digestibility is an important factor to estimate
the protein availability for intestinal absorption after digestion
reﬂecting on the efﬁciency of protein utilization on diet (FAO/WHO/
UNU, 2007). The in vitro protein digestibility (IVPD) assay is a
widely used method to determine the digestibility parameter. The
IVPD mimics conditions simulated by the digestive processes
occurring in the human gastrointestinal tract through proteolytic
enzymes (i.e. pepsin-pancreatin enzyme system or papain system),
measuring the percentage of proteins which is hydrolyzed by such
enzymes (Hur, Jin, Lim, Decker, & Julian, 2011). This method is
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(Pires, Vieira, Jose, & Neuza, 2006).
The AAS does not consider whether the protein is digestible or
not (Mokrane et al., 2010). Therefore, protein digestibility-corrected
amino acid score (PDCAAS) is a recognized and approved method
for evaluating protein quality taking into account the AAS and the
digestibility parameter of the food matrix. This parameter derives
from the AAS, and is corrected based on the digestibility assay of
the protein (FAO/WHO/UNU, 2007).
Several reports investigated the technological properties of
whey protein as ingredients into a wide variety of products
(Bhushan & Etzel, 2009; Urista et al., 2011; Youn-Ho & Lawrence,
2002) such as, infant formula (Jost, Maire, Maynard, & Secretin,
1999; L€onnerdal, 2014; Shuang, Zhang, Ming-Ming, Huang, & Yi-
Ping, 2014); in addition, studies were already undertaken to
correlate the intake of whey protein supplements with physical
performance (Hoffman, Tranchina, Rashti, Kang, & Faigenbaum,
2008; Hulmi, Christopher, & Jeffrey, 2010; Uchida, Bacurau, Aoki,
& Bacurau, 2008). However, there is limited information
regarding the WP supplement protein quality. In this context, the
purpose of this study was to investigate the protein quality of
commercial WP supplements produced by U.S. and Brazilian
companies based on in vitro protein digestibility (IVPD) assay, EAA,
AAS and PDCAAS.2. Material and methods
2.1. Sampling
All samples (WP, soy protein, and caseinate isolate powder) used
in the present study were acquired from a commercial retailer
specialized on nutritional supplements. Fifteen WP supplements
manufactured at different countries were investigated, eight from
USA companies (WP-USA), and seven from Brazilian companies
(WP-BRA). In addition, supplements manufactured with soy pro-
tein and caseinate isolate powder were used as references.Fig. 1. The in vitro protein digestibility values (%) of WP-USA, WP-BRA, soy isolate and
caseinate isolate supplements. aed Different letters denote difference at 95% of conﬁ-
dence level (P < 0.05) (n ¼ 7). WP-USA ¼whey protein supplements produced by USA
companies; WP-BRA ¼ whey protein supplements produced by Brazilian companies.2.2. In vitro protein digestibility (IVPD) assay
The in vitro protein digestibility was evaluated based on method
described by Akeson and Stahmann (1964), with modiﬁcations.
Brieﬂy, aliquots of 250 mg of each sample or 250 mL of deionized
water (for the blank) were suspended in 15mL of 0.1mol equi/L HCl
containing 1.5 mg/mL pepsin (Sigma®, St. Louis, MO, USA), and
incubated for 3 h at 37 C in a water bath. The pepsin hydrolysis
ceased after neutralization with the addition of 7.5 mL of 0.5 mol
equi/L of NaOH. Then, the pancreatic digestion initiated with the
addition of 10 mL of 0.2 mol/L phosphate buffer (pH 8.0) containing
10 mg of pancreatin (Sigma®, St. Louis, MO, USA) with 1 mL of
0.005 mol/L sodium azide to prevent microbial growth, and were
incubated at 37 C overnight. After the pancreatic hydrolysis, 1 mL
of 10 g/100 mL of trichloroacetic acid was added, followed centri-
fugation at 503  g for 20 min. The supernatant was collected, and
the total protein content was estimated based on the nitrogen
content using Kjeldahl AOAC method 930.29 (AOAC, 2012), For
comparative purpose, supplements manufactured with soy protein
and caseinate isolate powder were used as references. The IVPD
values were calculated according to the equation:
% Digestibility ¼ ðNs NbÞ=Ns 100
where Ns and Nb represent the nitrogen content in the sample and
in the blank, respectively.2.3. Determination of essential amino acids (EAA) content
The essential amino acids (histidine, threonine, methionine,
valine, phenylalanine, isoleucine, leucine and lysine) content were
analyzed by high-performance liquid chromatography, using
method described by Alvares et al. (2012). Brieﬂy, 50 mL of sample
previously diluted according to the manufacturer's recommenda-
tion, was mixed with 50 mL of 1.5 mol/L perchloric acid (v/v). After
2 min at room temperature, 1.125 mL of ultrapure water and 25 mL
of 2 mol/L potassium carbonate were added. The tubes were
centrifuged at 10,000  g for 1 min, and then, 100 mL of the su-
pernatant was diluted with 100 mL of 1.2 g/100 mL benzoic acid and
1.4 mL of ultrapure water. The amino acids were identiﬁed using a
pre-column derivation with o-ophthaldialdehyde (Sigma®, St.
Louis, MO, USA). The HPLC instrument was equipped with a qua-
ternary pump (LC-20AD, Shimadzu Corporation, Japan), a 5 mm
reverse-phase C18 column (4.6 mm ID  150 mm from Supelco®,
Bellefonte, PA, USA) guarded by a 5 mm reverse-phase C18 guard
column Ascentis® (4.0mm ID 20mm from Sigma®, Bellefonte, PA,
USA), and a ﬂuorescence detector (RF-10AXL, Shimadzu Corpora-
tion, Japan) monitoring excitation and emission wavelengths at
340 nm and 455 nm, respectively. The samples were separated by
mobile phase gradient using 0.1 mol/L sodium acetate (pH 7.2), and
methanol at 1.1 mL/min ﬂow. The total running time per sample
was 49 min and the column temperature was kept at room
temperature.
2.4. Amino acid score (AAS) and protein digestibility-corrected
amino acid score (PDCAAS)
The AAS was calculated by dividing each individual amino acid
content by their respective reference value, considering the daily
amino acid requirement for non-athletic individuals (Joint WHO/
FAO/UNU Expert Consultation, 2007) and physically active adults
(Jeukendrup & Gleeson, 2009). The PDCAAS were calculated by
multiplying the most limiting AAS value of each essential amino
acid by the protein digestibility.
2.5. Statistical analysis
Eight different WP supplements manufactured in the USA (WP-
USA), and seven different ones manufactured in Brazil (WP-BRA)
were used in this study. Seven distinct samples were used for each
manufacturer (n ¼ 7). Differences on EAA, AAS and PDCAAS values
between WP-USA and WP-BRA were evaluated using Student's t
test. In addition, the difference on IVPD amongst WP supplements
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and caseinate isolate powders were investigated using ANOVA
followed by Tukey's test. All statistical analyses were performed
using Graphpad 5 Prism (La Jolla, CA, USA) considering 95% of
conﬁdence level. The results were expressed as mean ± standard
error.3. Results and discussion
WP-USA supplements exhibited greater IVPD (P < 0.05) than
WP-BRA supplements (Fig. 1). To the best of our knowledge there is
lack of information regarding the digestibility of WP supplements.
Nevertheless, this parameter is an important factor to determine
the nutritional quality of these products (FAO/WHO/UNU, 2007).
The variation on IVPD values is potentially explained by differences
on the overall composition of such supplements, particularly with
respect to the protein quality (Eriksen et al., 2010; Sindayikengera
& Wen-shui, 2006). In addition, differences on protein quality is
possibly related to processing conditions, including farm practices,
period of lactation, whey extractionmethod, method of puriﬁcation
(membrane ﬁltration vs ion exchange), and thermal processing
(Onwulata, Konstance, & Tomasula, 2004; Walstra et al., 2006). In
this study the total protein values ranged from 61.2 ± 2.41 g/100 g
to 79.5 ± 2.03 g/100 g (WP-USA) and 48.1 ± 1.77 g/100 g to
75.2 ± 2.43 g/100 g (WP-BRA). There was a signiﬁcant difference in
protein content between the WP-USA and WP-BRA supplements
(72.83 ± 5.8 g/100 g vs 63.36 ± 8.4 g/100 g). This difference may be
related to the supply of amino acids offered by these products.
Proteinmodiﬁcation plays an important role on food quality and
its attributes. Modiﬁcations such as amino acid side chain oxida-
tion; proteineprotein cross-linking and backbone cleavage can
negatively inﬂuence product properties including a decrease in
nutritional value, digestibility, functionality, and health claims
(Kerwin & Remmele, 2007).
Amongst the WP supplements available the most widely
consumed ones are formulated using whey protein concentrate
(WPC), whey protein isolate (WPI), or a blend of concentrate and
isolate. The difference between WPC and WPI depends on the
processing condition during the protein puriﬁcation step
(Maughan, 2013; Urista et al., 2011), which affects the protein
content; WPC and WPI usually contain 35e80 g/100 g, and 90 g/
100 g of protein content, respectively (Carunchia, Croissant, &
Drake, 2005).
During the manufacture of WPC and WPI, the thermal pro-
cessing potentially negatively affect protein quality, biological
availability of amino acids, and digestibility (Ruﬁan-Henares,
Andrade, Jimenez-Perez, & Morales, 2007). Thus, according to
Lacroix et al. (2008) the greater the processing temperature the
greater is the negative impact on protein digestibility.
Furthermore, the IVPD value of soy protein powders (55.2 ± 4.0)
and caseinate isolate powder (83.73 ± 1.3) were lower (P < 0.05;
Fig. 1) than WP-USA and WP-BRA supplements. Different proteins
sources promote distinct positive effects for both protein supple-
mentation, and athletic performance (Hoffman & Falvo, 2004). The
consumption of different proteins sources stimulates different
anabolic responses depending on the tissue type (Phillips, 2011;
Tang, Moore, Kujbida, Tarnopolsky, & Phillips, 2009). Tang et al.
(2009) investigated the inﬂuence of isonitrogenous quantities of
soy, casein, and whey protein on the stimulation of muscle protein
synthesis, and concluded that the ingestion of whey protein pro-
moted greater increase on blood essential and branched-chain
amino acids content than either casein or soy. This effect may be
related to how quickly whey proteins are digested (Hall, Millward,
Long, & Morgan, 2003).The IVPD values reported on this study are in agreement with
those documented by Mokrane et al. (2010) and Sindayikengera
and Wen-shui (2006). Furthermore, Pires et al. (2006) evaluated
the inﬂuence of protein source on the protein digestibility, and
reported that soy protein exhibited the lowest protein digestibility
when compared to casein and whey proteins. This observation may
be attributed to the fact that vegetable sources contain anti-
nutritional factors that form a more complex protein structure,
which may decrease protein digestibility (Butts, Monro, &
Moughan, 2012; Lowery, Edel, & McBride, 2012; Pires et al.,
2006). In terms of casein proteins, although they exhibit high bio-
logical value, the caseins undergo less digested and absorbed than
whey proteins (Sindayikengera et al., 2006; Wilson & Wilson,
2006) because of coagulation of caseins at the acidic pH of the
digestive tract (Marcus et al., 2010).
Essential amino acid content, AAS and PDCAAS of WP-USA and
WP-BRA, calculated based on the reference values suggested by the
Joint WHO/FAO/UNU Expert Consultation (2007), are exhibited on
Table 1. In terms of individual essential amino acid contents,
isoleucine, lysine, and valine exhibited similar (P > 0.05) values
between WP-USA and WP-BRA. Leucine and phenylalanine were
greater (P < 0.05) in WP-USA than their counterparts while, histi-
dine, methionine and threonine were greater (P < 0.05) in WP-BRA
than in WP-USA. Supplements manufactured by both USA and
Brazilian companies received high scores for most of the essential
amino acids investigated. However, WP-BRA supplements
demonstrated leucine values lower than 1.0; essential amino acids
exhibiting AAS below 1.0 were regarded as a limiting amino acid
(Joint WHO/FAO/UNU Expert Consultation, 2007). Regarding the
AAS values, both WP-USA and WP-BRA exhibited similar (P > 0.05)
scores for isoleucine, lysine, and valine. In addition, leucine and
phenylalanine were greater (P < 0.05) in WP-USA than their Bra-
zilian counterparts, while histidine, methionine and threonine
were greater (P < 0.05) in WP-BRA than in WP-USA. Based on the
corrected digestibility calculation it was observed that the PDCAAS
values were numerically lower than 1.0 for threonine and valine in
WP-USA, and for isoleucine and leucine in WP-BRA. In addition,
WP-BRA exhibited the lowest values for PDCAAS when compared
to WP-USA due to the greater in vitro protein digestibility observed
on WP-USA than WP-BRA. Therefore, WP-USA PDCAAS values
demonstrated a smaller decrease when compared to their respec-
tive AAS values. This observation corroborates the usefulness of
PDCAAS to better investigate the amino acidic quality of food
products as the food matrix digestibility is considered (Mokrane
et al., 2010).
International health agencies established the daily protein
intake requirement based on non-athletic individuals as a recom-
mendation for the general population (Joint WHO/FAO/UNU Expert
Consultation, 2007). At cellular level, the increased requirement for
protein input on strength-trained athletes reﬂects the biological
adaptation to support muscle protein accretion stimulated by
increased protein synthesis rather than protein catabolism; thus,
adult athletes potentially require greater protein intake (up to 125%
accretion) than non-athletic individuals (Lemon, 1997; Phillips,
2014). Therefore, to investigate if WP supplements meet sug-
gested adult athlete requirements (Jeukendrup & Gleeson, 2009), a
2-fold adjustment was applied to the recommended values of the
Joint WHO/FAO/UNU Expert Consultation (2007).
The AAS and PDCAAS values for WP-USA and WP-BRA were
calculated based on the recommendation for adult athletes as
exhibited in Table 2. Both supplements demonstrated AAS values
lower than 1.0 for the majority of the essential amino acids evalu-
ated. However, histidine, lysine, and phenylalanine values on WP-
USA, and histidine, lysine, methionine, and phenylalanine values
onWP-BRAwere above the reference value. In terms of AAS values,
Table 1
Essential amino acids (EAA) content, amino acid score (AAS) and the protein digestibility-corrected amino acid score (PDCAAS) values calculated forWP-USA supplements and
WP-BRA supplements.
EAA Referencea EAA content (mg kg1) AAS PDCAAS
WP-USA WP-BRA WP-USA WP-BRA WP-USA WP-BRA
His 10 17.4 ± 1.9* 24.1 ± 3.9 2.1 ± 0.4* 3.2 ± 0.7 1.9 ± 0.4* 2.7 ± 0.6
Ile 20 22.2 ± 3.0 20.7 ± 3.1 1.2 ± 0.1 1.1 ± 0.1 1.1 ± 0.1 0.9 ± 0.1
Leu 39 58.0 ± 5.0* 30.9 ± 6.3 1.6 ± 0.7* 0.9 ± 0.1 1.4 ± 0.7* 0.7 ± 0.1
Lys 30 119.4 ± 22.6 146.4 ± 44.2 4.3 ± 0.8 5.9 ± 1.0 3.9 ± 0.7 5.3 ± 0.9
Met 10 11.5 ± 0.9* 16.5 ± 2.2 1.2 ± 0.1* 1.9 ± 0.2 1.1 ± 0.09* 1.7 ± 0.2
Phe 25 53.4 ± 10.4* 41.6 ± 8.6 2.3 ± 0.4* 1.9 ± 0.3 2.1 ± 0.4* 1.6 ± 0.3
Thr 15 17.5 ± 1.7* 19.3 ± 1.4 1.0 ± 0.2* 1.7 ± 0.2 0.9 ± 0.3* 1.5 ± 0.3
Val 26 25.0 ± 5.2 25.7 ± 3.7 1.0 ± 0.2 1.2 ± 0.1 0.9 ± 0.2 1.0 ± 0.1
The values are mean ± standard error (n ¼ 7).
*Denotes difference between WP-USA a4nd WP-BRA (P < 0.05).
EAA ¼ essential amino acid; AAS ¼ amino acid score; PDCAAS ¼ protein digestibility-corrected amino acid score; WP-USA ¼ whey protein supplements produced by USA
companies; WP-BRA ¼ whey protein supplements produced by Brazilian companies.
a Reference values (mg kg1) for daily intake of amino acids for non-athletic adult (Joint WHO/FAO/UNU Expert Consultation, 2007).
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USA than in WP-BRA, whereas histidine, methionine and threo-
nine values were greater (P < 0.05) in WP-BRA than in WP-USA. As
for PDCAAS values, only lysine and phenylalanine in WP-USA and
histidine and lysine on WP-BRA demonstrated scores above the
suggested values for adult athlete. Furthermore, WP-USA and WP-
BRA supplements exhibited similar numeric values for isoleucine,
lysine, and valine in both AAS and PDCAAS parameters.
The AAS is a ratio between the actual content of individual
amino acids in food/diet and the recommended value of such
amino acid (Joint WHO/FAO/UNU Expert Consultation, 2007). This
parameter does not consider whether the protein is digestible or
not (Mokrane et al., 2010); thus, PDCAAS was developed to adjust
the AAS according to the food protein digestibility, and has been
widely used to evaluate the protein quality of food products (Joint
WHO/FAO/UNU Expert Consultation, 2007). According to Boye,
Wijesinha-Bettoni, and Burlingame (2012), PDCAAS values greater
than 1.0, should be considered equal to 1.0 as they fully meet the
daily requirement. In the present study, the essential amino acids
with PDCAAS values below 1.0, considering the suggested reference
for non-athletic adult, were threonine and valine, and isoleucine
and leucine, on WP-USA and on WP-BRA supplements, respec-
tively. However, when the recommended PDCAAS values for adult
athletes are considered, only lysine and threonine in WP-USA, and
histidine and lysine on WP-BRA exhibited values higher than theTable 2
Amino acid (AAS) and protein digestibility-corrected amino acid scores (PDCAAS)
scores of WP-USA and WP-BRA supplements calculated for adult athletes.
EAA Referencea AAS PDCAAS
WP-USA WP-BRA WP-USA WP-BRA
His 20 1.1 ± 0.2* 1.6 ± 0.3 0.9 ± 0.2* 1.4 ± 0.3
Ile 40 0.6 ± 0.07 0.6 ± 0.07 0.5 ± 0.06 0.4 ± 0.06
Leu 78 0.9 ± 0.3* 0.5 ± 0.08 0.8 ± 0.3* 0.4 ± 0.08
Lys 60 2.1 ± 0.4 3.4 ± 0.9 1.9 ± 0.3 3.0 ± 0.8
Met 20 0.6 ± 0.05* 1.0 ± 0.1 0.5 ± 0.04* 0.8 ± 0.1
Phe 50 1.2 ± 0.2* 1.0 ± 0.1 1.0 ± 0.2* 0.8 ± 0.1
Thr 30 0.6 ± 0.1* 0.8 ± 0.1 0.5 ± 0.1* 0.7 ± 0.1
Val 52 0.6 ± 0.1 0.6 ± 0.08 0.5 ± 0.1 0.5 ± 0.07
The values are mean ± standard error (n ¼ 7).
*Denotes difference between WP-USA and WP-BRA (P < 0.05).
AAS ¼ amino acid score; PDCAAS ¼ protein digestibility-corrected amino acid; WP-
USA ¼ whey protein supplements manufactured by USA companies; WP-
BRA ¼ whey protein supplements manufactured by Brazilian companies.
a Reference values (mg kg1) for adult athlete suggested by Jeukendrup and
Gleeson (2009) based on daily intake of amino acids for non-athletic adult (Joint
WHO/FAO/UNU Expert Consultation, 2007).recommended values. According to Phillips (2011), the high-quality
protein products (PDCAAS > 1.0) contain increased levels of
branched-chain amino acids. Several authors previously reported
that the high content of BCAA, particularly leucine, are important
stimulating factors for protein synthesis (Hoffman et al. 2008;
Hulmi et al., 2010; Uchida et al., 2008). WP-USA supplements
contained PDCAAS values of BCAA greater than the recommended
for non-athletic adults, while on WP-BRA supplements only one
BCAAs (valine) score was greater than 1.0. Nevertheless, consid-
ering the recommended values for adult athletes, neither WP-USA
norWP-BRA supplements reached the value. According to Judy and
Ira (2001), the addition of speciﬁc amino acids such as BCAA, are
frequently used to fortify protein supplements, which is used as an
alternative to nullify or even reverse the negative effects of product
processing on these essential amino acids contents.
4. Conclusion
In conclusion,WP-USA supplements exhibited better nutritional
quality, based on in vitro digestibility than the WP-BRA counter-
parts. Considering the WHO/FAO/UNU protein standard for non-
athletic adults, the WP-USA and WP-BRA supplements scored
high AAS values. In addition, the PDCAAS values on both supple-
ment groups were >1.0, with exception of threonine and valine in
WP-USA, and isoleucine and leucine in WP-BRA. Nevertheless,
when the AAS and PDCAAS were calculated based on the sugges-
tion for adult athletes, both supplement groups exhibited subop-
timal score values for several EAA. Based on these ﬁndings, whey
protein manufactures should revise their processing techniques in
order to optimize the protein quality of WP products.
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